Every 8-K that SkyAI, Inc. (SKYA) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SKYA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SKYA filings page.
SkyAI, Inc., a Nevada corporation listed on the Nasdaq Capital Market, reports that its board formed a special committee of independent directors to evaluate an unsolicited, non-binding proposal from Forward Industries, Inc. for a potential all-stock business combination.
After completing this review, both the special committee and the full board unanimously concluded that the proposal was not in the best interests of SkyAI shareholders. The company states that it is not pursuing this transaction at this time.
SkyAI, Inc., formerly Sharps Technology, Inc., has amended its Nevada articles of incorporation to change its corporate name and align with a new AI-driven strategy. Its common stock now trades on Nasdaq under the ticker SKYA and its warrants under SKYAW, replacing STSS and STSSW. The company is pivoting from its legacy operations to build an agentic finance platform for the Global South, combining artificial intelligence with blockchain-based infrastructure, including stablecoin rails and the Solana network. It has opened an operational headquarters in Hong Kong to support licensing, hiring and regional expansion, and discloses extensive operational, legal, regulatory, cybersecurity and competitive risks tied to its AI and digital asset-focused strategy, including evolving AI regulation such as the EU’s AI Act.
SkyAI, Inc. entered into an employment agreement with Arthur Levine and appointed him as its Chief Financial Officer, effective May 22, 2026. Levine, age 68, had been serving as interim CFO since February 2026 and has extensive prior CFO experience at public companies.
Under the agreement, he will receive a base salary of $400,000 per year and is eligible for an annual cash bonus equal to 50% of base salary, contingent on performance and continued employment. He will also be considered for additional equity-based awards at the board’s discretion.
If SkyAI terminates him without cause or he resigns for good reason, he is entitled to severance equal to one times base salary and accelerated vesting of outstanding equity, subject to a release. If such a termination occurs in connection with a change in control, cash severance increases to three times base salary, with equity also accelerating.
Sharps Technology, Inc. appointed Arthur Levine as interim Chief Financial Officer under a fee agreement with DLA, LLC. His initial term is three months starting February 17, 2026, with any extension at the company’s discretion, and DLA will be paid $450 per hour for his services.
Levine is an experienced financial executive who has held CFO roles at public companies in healthcare and energy-related services and is a Certified Public Accountant. He has also signed the company’s standard indemnification agreement. Executive Chairman Paul Danner will serve as Principal Financial Officer while the company conducts its search for a permanent CFO.
Sharps Technology, Inc. reported that on January 15, 2026 it entered into a 90-day lock-up agreement with Sol Markets, described as its strategic advisor. Under this agreement, Sol Markets agreed that for ninety days it will not offer, sell, pledge or otherwise dispose of any Sharps common stock or any securities that can be converted, exchanged or exercised into Sharps common stock that it beneficially owns or later acquires.
The company also noted that on January 16, 2026 it issued a press release announcing, among other items, its entry into this lock-up agreement. The lock-up terms are intended to temporarily restrict potential share sales by this advisor, and the full agreement and press release are included as exhibits to the report.
Sharps Technology, Inc. reported several corporate governance updates approved by its board of directors on January 15, 2026. The company adopted amended and restated bylaws that, among other changes, require stockholder actions to be taken at duly called meetings, introduce advance notice requirements for stockholder proposals and director nominations, and establish Nevada as the exclusive forum for certain legal actions.
The board also adopted an amended and restated Code of Business Conduct and Ethics, updating it for current governance, ethics, and compliance practices and streamlining overlapping company policies. In addition, the board approved charters for the Audit Committee, Compensation Committee, and Nominating Committee, formally setting out how these key board committees will operate.
Sharps Technology (STSS) reported results of its special meeting of stockholders. Of 26,600,848 shares eligible to vote as of September 16, 2025, 17,779,090 shares were present or represented by proxy, establishing a 66.9% quorum.
Stockholders elected Annemarie Tierney as director with 17,770,289 votes for and 8,801 withheld. Proposal 2 was approved with 17,750,927 votes for, 27,713 against, and 450 abstentions. Proposal 3 was approved with 17,743,259 votes for, 35,546 against, and 285 abstentions. Proposal 4 was approved with 16,802,916 votes for, 51,835 against, and 924,339 abstentions.
Sharps Technology, Inc. approved a 2025 share repurchase program authorizing the company to buy back up to $100,000,000 of its outstanding common stock. The program allows repurchases in the open market and through negotiated transactions, with the amount and timing of purchases depending on available capital, financial and operational performance, market conditions, securities law limits, and other factors, and does not obligate the company to repurchase any shares.
To facilitate these buybacks, Sharps Technology entered into an Open Market Share Repurchase Agreement with Cantor Fitzgerald & Co., which will act as a non-exclusive agent to repurchase shares under Rule 10b-18 of the Exchange Act. The agreement remains in effect until either party terminates it by written notice, and the company will pay the broker a commission of $0.02 per share repurchased.
Sharps Technology, Inc. disclosed that its Board of Directors has authorized a stock repurchase program. This program allows the company to buy back its common shares in the open market and through negotiated transactions, which can reduce the number of shares available in the market over time. The announcement was made via a press release dated October 2, 2025, which is included as an exhibit to the report.
Sharps Technology, Inc. entered into a confidential settlement agreement to resolve litigation with Barry Berler and several Plasto-related entities.
Under this settlement, Sharps will transfer certain assets to Plasto Technology Group LLC, including all of its right, title and interest in the issued and outstanding shares of its Hungarian subsidiary, Safegard Medical Kft, as well as specified patents, registered trademarks and associated goodwill.
All parties agree to unconditionally and irrevocably release one another and their representatives from all claims in the litigation, and the agreement specifies that no party admits fault, responsibility or liability. Sharps also provides unaudited pro forma condensed consolidated financial information as an exhibit to show the impact of these changes.
Sharps Technology, Inc. entered into a Waiver and Consent on September 26, 2025 with certain security holders who collectively beneficially own at least 50.1% of the outstanding Registrable Securities under its August 25, 2025 Registration Rights Agreement. This Waiver and Consent waives the original September 29, 2025 filing date and extends the deadline for Sharps Technology to file its initial resale registration statement with the SEC to the 60th calendar day following the Closing Date defined in that agreement. The company has filed the Waiver and Consent and the Registration Rights Agreement as exhibits for investors to review.